| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |